Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease	Immunoglobulin G4-Related Disease, autoimmune disease, immune system disorder	Recruiting	Phase 2	2025-09-03		NCT07148791

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chinese PLA General Hospital	238
Xuzhou Medical University	17

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital	Beijing	China	2

Clinical trials